DB-2304

DualityBio Inc. · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	DB-2304
Sponsor	DualityBio Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE Participants (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

DB-2304 CI brief — competitive landscape report
DB-2304 updates RSS · CI watch RSS
DualityBio Inc. portfolio CI